Nuclein is a brand that specializes in the development of innovative solutions for infectious disease diagnosis. Their flagship product, the Nuclein PCR device, is a rapid and handheld test that offers a sample-to-answer outcome in just one hour. This all-in-one system is designed to be affordable and easy to use, making it ideal for point-of-care testing in CLIA-waived environments.

The Nuclein DASH Rapid PCR System, powered by their advanced technology, delivers results in as little as 15 minutes with a central lab quality limit of detection of 150 cp/mL. It is multiplex-capable and can accommodate a wide range of sample types, ensuring its versatility in various clinical settings. With a small and intuitive design, measuring only 4 wide, it offers the best-in-class sensitivity among its competitors.

Clinical trial data has shown that the DASH Rapid PCR System is accurate and efficient in real-life settings, demonstrating 96% sensitivity and 98% specificity. The system has achieved an overall agreement of 98% compared to the Cepheid GeneXpert. For more information about their technology, careers, or to get in touch, visit Nuclein's website.

Please note that certain indications require separate FDA clearances and may not be commercially available at this time